At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
IMRA Bitwise MARA Option Income Strategy ETF
Post-Mkt 03-23 19:19:08 EDT
14.06
+0.54
+4.01%
盘后14.06
+0.000.00%
16:10 EDT
High14.29Low13.79Vol1.79K
Open13.79D1 Closing13.52Amplitude3.71%
Mkt Cap2.53MTradable Cap2.53MTotal Shares180.00K
T/O25.27KT/O Rate0.99%Tradable Shares180.00K
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Why MARA Holdings (MARA) Is Down 9.2% After Pivoting Toward AI Data Centers Over Bitcoin Sales
Simply Wall St.  ·  03-22 23:07
Why MARA Holdings (MARA) Is Down 9.2% After Pivoting Toward AI Data Centers Over Bitcoin Sales
MARA Holdings Slides as Insider Sales Spook Traders
TIPRANKS  ·  03-21 22:02
MARA Holdings Slides as Insider Sales Spook Traders
Mara Holdings CEO Fred Thiel disposes of USD 252,296 in common shares
Reuters  ·  03-20
Mara Holdings CEO Fred Thiel disposes of USD 252,296 in common shares
Mara CFO Salman Hassan Khan disposes of USD 146880 in common shares
Reuters  ·  03-20
Mara CFO Salman Hassan Khan disposes of USD 146880 in common shares
Moderately bullish activity in Mara Holdings with shares up 0.22%
TIPRANKS  ·  03-20
Moderately bullish activity in Mara Holdings with shares up 0.22%
Mixed options sentiment in Mara Holdings with shares up 0.11%
TIPRANKS  ·  03-17
Mixed options sentiment in Mara Holdings with shares up 0.11%
Riot Platforms up 3.5%, Hut 8 up 7.1%, Mara Holdings up 2.8%
THOMSON REUTERS  ·  03-16
Riot Platforms up 3.5%, Hut 8 up 7.1%, Mara Holdings up 2.8%
Proshares Bitcoin Strategy ETF up 4.3%, Ishares Bitcoin Trust up 4.2%
THOMSON REUTERS  ·  03-16
Proshares Bitcoin Strategy ETF up 4.3%, Ishares Bitcoin Trust up 4.2%
U.S.-Listed Crypto Stocks Rise as Bitcoin Briefly Hits More Than Five-Week High
THOMSON REUTERS  ·  03-16
U.S.-Listed Crypto Stocks Rise as Bitcoin Briefly Hits More Than Five-Week High
BUZZ-U.S. STOCKS ON THE MOVE-Sable Offshore, Nebius, Upstart
Reuters  ·  03-16
BUZZ-U.S. STOCKS ON THE MOVE-Sable Offshore, Nebius, Upstart
BUZZ-Crypto stocks gain as bitcoin hits 5-week high
Reuters  ·  03-16
BUZZ-Crypto stocks gain as bitcoin hits 5-week high
Proshares Bitcoin Strategy ETF up 3.6%, Ishares Bitcoin Trust up 3.5%
THOMSON REUTERS  ·  03-16
Proshares Bitcoin Strategy ETF up 3.6%, Ishares Bitcoin Trust up 3.5%
Crypto Stocks Rise Premarket as Bitcoin Briefly Hits More Than Five-Week High
THOMSON REUTERS  ·  03-16
Crypto Stocks Rise Premarket as Bitcoin Briefly Hits More Than Five-Week High
MARA Holdings Attracts Bullish Traders Amid Volatile Rebound
TIPRANKS  ·  03-14
MARA Holdings Attracts Bullish Traders Amid Volatile Rebound
Did MARA’s Loss-Making 2025 Pivot and AI Options Frenzy Just Shift MARA Holdings’ (MARA) Investment Narrative?
Simply Wall St.  ·  03-14
Did MARA’s Loss-Making 2025 Pivot and AI Options Frenzy Just Shift MARA Holdings’ (MARA) Investment Narrative?
Why MARA Holdings Shares Are Surging Friday
Benzinga  ·  03-14
Why MARA Holdings Shares Are Surging Friday
Mara Holdings rises 10.0%
TIPRANKS  ·  03-14
Mara Holdings rises 10.0%
Proshares Bitcoin Strategy ETF, Ishares Bitcoin Trust up 3.7% Each
THOMSON REUTERS  ·  03-13
Proshares Bitcoin Strategy ETF, Ishares Bitcoin Trust up 3.7% Each
Riot Platforms up 4.6%, Hut 8 up 4%, Mara Holdings Gains 5.3%
THOMSON REUTERS  ·  03-13
Riot Platforms up 4.6%, Hut 8 up 4%, Mara Holdings Gains 5.3%
Coinbase Global up 5%, U.S.-Listed Shares of Bitfarms up 4.8%, Strategy up 5.5%
THOMSON REUTERS  ·  03-13
Coinbase Global up 5%, U.S.-Listed Shares of Bitfarms up 4.8%, Strategy up 5.5%

Introduction

Company Name.
Bitwise MARA Option Income Strategy ETF
Affiliated Markets:
ARCA
Listing Date:
--
Main Business:
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas. IMARA Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Issue price:
--